Seeking Alpha

Neurocrine Biosciences (NBIX +2%) gets a lift after being initiated with a Buy at Roth Capital...

Neurocrine Biosciences (NBIX +2%) gets a lift after being initiated with a Buy at Roth Capital with a price target of $14.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)